Literature DB >> 33090437

Prediction of in-hospital mortality of patients with SARS-CoV-2 infection by comorbidity indexes: an Italian internal medicine single center study.

A De Giorgi1, F Fabbian, S Greco, E Di Simone, R De Giorgio, A Passaro, G Zuliani, R Manfredini.   

Abstract

OBJECTIVE: Clinical outcomes in patients hospitalized for severe acute respiratory syndrome due to coronavirus (SARS-CoV-2) infection seems to be closely related with burden of comorbidities. A comorbidity score could help in clinical stratification of patients admitted to internal medicine units. Our aim was to assess a novel modified Elixhauser index (mEi) and the Charlson Comorbidity Index (CCI) for predicting in-hospital mortality (IHM) in internal medicine patients with SARS-CoV-2 infection. PATIENTS AND METHODS: This single-center retrospective study enrolled all consecutive patients discharged from internal medicine unit with confirmed SARS-CoV-2 infection. Both the mEi and CCI were easily calculated from administrative data. Comorbidity scores were tested using receiver operating characteristic (ROC) analysis, and the respective area under the curve (AUC).
RESULTS: The total sample consisted of 151 individuals, and 30 (19.9%) died during their hospital stay. Deceased subjects were older (82.8±10.8 vs. 63.3±18.1 years; p<0.001) and had a higher burden of comorbidities: the mEi and CCI were 29.9±11 vs. 8.8±9.2 and 4.6±2.6 vs. 1.2±2 (p<0.001), respectively. Only the mEi was independently associated with IHM (OR 1.173), and ROC curves analysis showed that the AUCs were 0.863 and 0.918 for the CCI and for mEi, respectively.
CONCLUSIONS: In patients admitted to internal medicine wards with SARS-CoV-2 infection, the mEi showed a better performance in predicting IHM than CCI.

Entities:  

Mesh:

Year:  2020        PMID: 33090437     DOI: 10.26355/eurrev_202010_23250

Source DB:  PubMed          Journal:  Eur Rev Med Pharmacol Sci        ISSN: 1128-3602            Impact factor:   3.507


  7 in total

1.  Competing-risk analysis of coronavirus disease 2019 in-hospital mortality in a Northern Italian centre from SMAtteo COvid19 REgistry (SMACORE).

Authors:  Valentina Zuccaro; Ciro Celsa; Margherita Sambo; Salvatore Battaglia; Paolo Sacchi; Simona Biscarini; Pietro Valsecchi; Teresa Chiara Pieri; Ilaria Gallazzi; Marta Colaneri; Michele Sachs; Silvia Roda; Erika Asperges; Matteo Lupi; Alessandro Di Filippo; Elena Seminari; Angela Di Matteo; Stefano Novati; Laura Maiocchi; Marco Enea; Massimo Attanasio; Calogero Cammà; Raffaele Bruno
Journal:  Sci Rep       Date:  2021-01-13       Impact factor: 4.379

2.  Do Sex-Related Differences of Comorbidity Burden and/or In-Hospital Mortality Exist in Cancer Patients? A Retrospective Study in an Internal Medicine Setting.

Authors:  Alfredo De Giorgi; Fabio Fabbian; Rosaria Cappadona; Ruana Tiseo; Christian Molino; Elisa Misurati; Edoardo Gambuti; Caterina Savriè; Benedetta Boari; Valeria Raparelli; Roberto Manfredini
Journal:  Life (Basel)       Date:  2021-03-22

3.  Clinical characteristics of Japanese patients with moderate to severe COVID-19.

Authors:  Ryota Otoshi; Eri Hagiwara; Takaaki Kitayama; Takafumi Yamaya; Katsuyuki Higa; Kota Murohashi; Yozo Sato; Erina Tabata; Ryota Shintani; Hiroko Okabayashi; Satoshi Ikeda; Takashi Niwa; Atsuhito Nakazawa; Tsuneyuki Oda; Ryo Okuda; Akiamasa Sekine; Hideya Kitamura; Tomohisa Baba; Shigeru Komatsu; Takashi Ogura
Journal:  J Infect Chemother       Date:  2021-03-04       Impact factor: 2.211

Review 4.  Pre-existing atrial fibrillation is associated with increased mortality in COVID-19 Patients.

Authors:  Marco Zuin; Gianluca Rigatelli; Claudio Bilato; Francesco Zanon; Giovanni Zuliani; Loris Roncon
Journal:  J Interv Card Electrophysiol       Date:  2021-04-15       Impact factor: 1.900

5.  Proteomic analysis of cardiometabolic biomarkers and predictive modeling of severe outcomes in patients hospitalized with COVID-19.

Authors:  Josep M Mercader; Aaron Leong; Philip H Schroeder; Laura N Brenner; Varinderpal Kaur; Sara J Cromer; Katrina Armstrong; Regina C LaRocque; Edward T Ryan; James B Meigs; Jose C Florez; Richelle C Charles
Journal:  Cardiovasc Diabetol       Date:  2022-07-21       Impact factor: 8.949

6.  Cardiac Biomarkers and Risk Scores in Relation with History of Atherosclerotic Cardiovascular Disease in Patients Admitted with COVID-19: The Experience of an Eastern European Center.

Authors:  Catalina Lionte; Victorita Sorodoc; Raluca Ecaterina Haliga; Cristina Bologa; Alexandr Ceasovschih; Oana Sirbu; Victoria Gorciac; Andrei-Costin Chelariu; Alexandra Stoica; Roxana Elena Tocila; Minerva Codruta Badescu; Irina-Iuliana Costache; Christiana Brigitte Sandu; Elisabeta Jaba; Laurentiu Sorodoc
Journal:  J Clin Med       Date:  2022-09-26       Impact factor: 4.964

7.  Prognostic Role of Metabolic Syndrome in COVID-19 Patients: A Systematic Review Meta-Analysis.

Authors:  Marco Zuin; Gianluca Rigatelli; Claudio Bilato; Carlo Cervellati; Giovanni Zuliani; Loris Roncon
Journal:  Viruses       Date:  2021-09-27       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.